Ignite Creation Date:
2025-12-24 @ 3:39 PM
Ignite Modification Date:
2026-01-03 @ 11:11 PM
Study NCT ID:
NCT01741792
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2012-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor:
Amgen Research (Munich) GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-28
First Submit QC Date:
None
Study First Post Date:
2012-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-26
Results First Submit QC Date:
None
Results First Post Date:
2015-07-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-09
Last Update Post Date:
2017-01-06
Last Update Post Date Type:
ESTIMATED